Omega 3 Market (By Type: Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-linolenic acid (ALA); By Source: Marine Source, Plant Source; By End-Use: Nutraceuticals & Supplements, Food & Beverages, Pharmaceuticals, Personal Care, Infant Formulas, Fish Feed, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
The global omega 3 market size was USD 8.06 billion in 2023, accounted for USD 8.67 billion in 2024, and is expected to reach around USD 17.86 billion by 2034, expanding at a CAGR of 7.5% from 2024 to 2034. The North America omega 3 market size reached USD 3.06 billion in 2023.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. omega 3 market size was estimated at USD 2.15 billion in 2023 and is predicted to be worth around USD 4.86 billion by 2034, at a CAGR of 7.7% from 2024 to 2034.
Asia Pacific's omega-3 market is anticipated to grow quickly throughout the course of the forecast timeframe. Consumer choice changes toward nutritious eating, beverage, and nutritional supplements are fueling income expansion in the Asia Pacific market. Additionally, the rising costs of hospitalization and unpleasant treatments have prompted customers to choose precautionary measures over curative ones, which means choosing healthy beverages and foods. This has led to a significant increase in demand for meals made with nutritional ingredients. Significant factors influencing the market's income expansion in this region include the abundance of materials available, the region's countries' affordable labor, and the existence of big corporations that employ omega-3 as a necessary element in a variety of goods.
Additionally, governments from different nations in this area are funding R&D projects to help women's nutritional status, which can aid in the fight against diseases like obesity and other cardiovascular conditions. To match the ongoing customer demand, numerous start-ups and new companies are expanding into this market sector with a variety of unique and improved products, including RuVega. This is helping the industry in this area grow in terms of revenue.
Market Overview
The omega-3 market is anticipated to be driven by rising consumer awareness of the benefits of polyunsaturated fatty acids for healthy eating and body composition, as well as rising investments in clinical research and development facilities. Additionally, rising chronic illness awareness and expanding product usage among active pharmaceutical ingredients (API) are anticipated to boost the market over the next several years.
The Omega-3 fatty acids help lower the risk of cardiopathy and support healthy skin. These are consumed along with a healthy lifestyle and regular physical activity to help reduce levels of certain blood fat (triglycerides) and raise levels of "good" cholesterol (HDL). Additionally, it's also desired to help with an immune disorder or high blood pressure. Chronic conditions are on the rise, and this ever-changing environment has helped the omega-3 market grow.
Consumers' growing knowledge of the importance of a balanced diet and the health advantages of omega-3 fatty acids, together with rising investments in clinical study and development, is anticipated to propel the global omega-3 market over the coming years. Omega-3 fatty acids are found in plants, nut oils, fish like salmon, tuna, and halibut, and other sea foods like krill and algae. These saturated fats are crucial for human development and growth in addition to brain function. Consuming omega-3 fatty acids reduces the risk of developing chronic illnesses like cancer, cardiovascular disease, or arthritis.
As health products gain popularity, top fish oil companies are focusing on delivering omega flax seed oil probiotics on the global market. Because of the intense rivalry, producers are adding more nutrients to their products. Leading fish oil companies are focusing on implementing new products into the global market due to the increased demand for oily fish from the pharmaceutical industry. Industries including fisheries, improved animal & pet food, supplementation & food ingredient, pharmaceuticals, and others all need large quantities of omega-3 fatty acids. Additionally, fish oil enhances cardiac health and helps the neurological system work properly.
Due to a greater understanding of the value of omega-3 fatty acids among both medical experts and the general public, fish oil demand has greatly increased. As a result, companies are expanding their lines of nutraceutical products that include boosted EPA and DHA. The growing need for DHA and EPA in human diets has had an influence on the market for oily fish worldwide.
Report Coverage | Details |
Market Size in 2023 | USD 8.06 Billion |
Market Size in 2024 | USD 8.67 Billion |
Market Size by 2034 | USD 17.86 Billion |
Growth Rate from 2024 to 2034 | CAGR of 7.5% |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | By Type, By Source, and By End-Use |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Growing health knowledge of omega-3 fatty acid consumption
Marketing tactics and product endorsements to spur market expansion
Extremely volatile fish oil prices
Fish oil allergies and difficult extraction methods
The use of omega-3 fatty acids for animal feeds and medications is growing
Because DHA can help lower the risks associated with cardiac illnesses, the segment is anticipated to experience strong revenue growth during the projected period. DHA also aids in lowering blood triglycerides while raising HDL cholesterol levels and blood flow while doing mental work. Attention Deficit/hyperactivity/ Hyperactivity Disorder may be helped by DHA (ADHD).
Omega-3 fatty acids can be used to address impulsive behaviors and concentration problems experienced by people with ADHD. DHA possesses anti-inflammatory qualities that could lower the risk of time of life illnesses including gingivitis (periodontitis) as well as other heart-related disorders, as well as ameliorate autoimmune ailments like rheumatoid arthritis.
The marine category had the greatest share of the revenue in 2023 and also is anticipated to raise its revenue quickly over the next few years. The ocean resource of omega-3 acids is fish or fish oil. Fish high in omega-3 fatty acids include tuna, mackerel, sardines, herring, and salmon. Because they include critical nutrients like DHA and EPA fish oil or vitamins are crucial for preventing heart disorders. Additionally, it lessens the likelihood of an irregular heartbeat and decreases the growth of arterial plaque. Omega-3 concentration powder made from organic fish oils and distributed by AlaskOmega was introduced on January 4, 2020. This product doesn't taste or feel fishy and provides 205 mg/g of DHA and also EPA.
During the anticipated period, several new introductions are anticipated to fuel market expansion. During the projected timeframe, the nuts & seed sector is expected to experience substantial revenue growth. ALA is found in seeds like flaxseeds, which is crucial for human wellness and has been linked to several advantages like less inflammation, enhanced cardiovascular health, and preservation of the brain against the signs of aging. Additionally, research conducted in test tubes has generated comparable results, with multiple studies demonstrating that flaxseed oil can slow the growth of breast carcinoma cells.
Due to changing food requirements among customers, particularly younger generations around the world, the nutraceutical & supplement sector, which accounted for the biggest revenue share in 2023, is anticipated to increase rapidly over the forecast period. Additionally, as a result of the COVID-19 outbreak and the growing need for omega-3 nutritional supplements, companies are investing in modern production technology to produce cutting-edge goods on a wider scale and satisfy continuous demand.
During the predicted period, the infant formulae segment experienced consistent growth. It is advised to add omega-3 fatty acids to infant formulae because they contain docosahexaenoic acid (DHA) as well as arachidonic acid (ARA), which are present in breast milk. These healthy fatty acids support a child's neurological and visual development.
Segments Covered in the Report
By Type
By Source
By End-Use
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Omega 3 Market
5.1. COVID-19 Landscape: Omega 3 Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Omega 3 Market, By Type
8.1. Omega 3 Market, by Type, 2024-2034
8.1.1 Docosahexaenoic acid (DHA)
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Eicosapentaenoic acid (EPA)
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Alpha-linolenic acid (ALA)
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Omega 3 Market, By Source
9.1. Omega 3 Market, by Source, 2024-2034
9.1.1. Marine Source
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Plant Source
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Omega 3 Market, By End-Use
10.1. Omega 3 Market, by End-Use, 2024-2034
10.1.1. Nutraceuticals & Supplements
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Food & Beverages
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Pharmaceuticals
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Personal Care
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Infant Formulas
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Fish Feed
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Omega 3 Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Source (2021-2034)
11.1.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Source (2021-2034)
11.2.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Source (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Source (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Source (2021-2034)
11.3.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Source (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Source (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Source (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Source (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Source (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End-Use (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Source (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End-Use (2021-2034)
Chapter 12. Company Profiles
12.1. Adisseo (France)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. ADM (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. ALGISYS LLC (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. BASF SE (Germany)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Biosearch Life (Spain)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. BTSA Biotechnologias Aplicadas S.L. (Spain)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Church & Dwight, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Colpex International
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Copeinca AS
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Corpesca S.A.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client